COST-EFFECTIVENESS OF QUADRIVALENT HPV VACCINATION IN GERMANY USING A DYNAMIC TRANSMISSION MODEL

被引：0
|
作者：
Schobert, D. [1 ]
Remy, V [2 ]
Schoeffski, O. [1 ]
机构：
[1] Univ Erlangen Nurnberg, Nurnberg, Germany
[2] Sanofi Pasteur MSD, Lyon, France
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.231
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A273 / A273
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of quadrivalent vaccine against human papilloma virus in Argentina based on a dynamic transmission model
    Pichon-Riviere, Andres
    Alcaraz, Andrea
    Caporale, Joaquin
    Bardach, Ariel
    Rey-Ares, Lucila
    Klein, Karen
    Calderon, Maria
    Augustovski, Federico
    Tatti, Silvio
    [J]. SALUD PUBLICA DE MEXICO, 2015, 57 (06): : 504 - 513
  • [22] Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model
    Pascal Crépey
    Louis Boiron
    Rafael Rodrigo Araujo
    Juan Guillermo Lopez
    Audrey Petitjean
    Expedito José de Albuquerque Luna
    [J]. BMC Public Health, 20
  • [23] Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model
    Crepey, Pascal
    Boiron, Louis
    Araujo, Rafael Rodrigo
    Lopez, Juan Guillermo
    Petitjean, Audrey
    de Albuquerque Luna, Expedito Jose
    [J]. BMC PUBLIC HEALTH, 2020, 20 (01)
  • [24] Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model
    Wolff, Ellen
    Widgren, Katarina
    Tomba, Gianpaolo Scalia
    Roth, Adam
    Lep, Tiia
    Andersson, Soeren
    [J]. PLOS ONE, 2021, 16 (05):
  • [25] COST-EFFECTIVENESS ANALYSIS OF HPV VACCINATION IN SLOVENIA
    Obradovic, M.
    Mrhar, A.
    Kos, M.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A272 - A272
  • [26] Cost-effectiveness of nonavalent HPV vaccination in the Netherlands
    Palmer, Cody
    Dolk, Christiaan
    Sabale, Ugne
    Wang, Wei
    Saxena, Kunal
    [J]. EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 312 - 323
  • [27] COST-EFFECTIVENESS OF SEASONAL VACCINATION WITH QUADRIVALENT INFLUENZA VACCINE IN PORTUGAL
    Almeida, J.
    Ferreira, C.
    Monteiro, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S651 - S651
  • [28] The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model
    Chesson, Harrell W.
    Markowitz, Lauri E.
    Hariri, Susan
    Ekwueme, Donatus U.
    Saraiya, Mona
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (06) : 1363 - 1372
  • [29] Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis
    Bresse, Xavier
    Goergen, Christoph
    Prager, Bernhard
    Joura, Elmar
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (02) : 269 - 281
  • [30] Cost-effectiveness of childhood rotavirus vaccination in Germany
    Aidelsburger, Pamela
    Grabein, Kristin
    Boehm, Katharina
    Dietl, Markus
    Wasem, Juergen
    Koch, Judith
    Ultsch, Bernhard
    Weidemann, Felix
    Wichmann, Ole
    [J]. VACCINE, 2014, 32 (17) : 1964 - 1974
12345